Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-lable, Randomized Phase III Study of PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer

NCT06616532 is registered in ClinicalTrials.gov with Biotheus Inc. as lead sponsor.

NCT NCT06616532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06616532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-lable, Randomized Phase III Study of PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer
Lead sponsor
Biotheus Inc.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
November 13, 2024
Completion date
December 25, 2028
Enrollment
404 (estimated)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

sclc